LYNN WHITTAKER: Open Payments
NPI 1114085248 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,432 in 92 payments from 21 companies in 2025. Trend: 2023 $558 · 2024 $1,052 · 2025 $1,432
Food & beverage: $1,432
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $249 |
| ABBVIE INC. | 20 | $242 |
| PFIZER INC. | 7 | $127 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $106 |
| GlaxoSmithKline, LLC. | 6 | $97 |
| Corium, LLC | 7 | $90 |
| Viatris Specialty LLC | 3 | $78 |
| Amgen Inc. | 5 | $73 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| Phathom Pharmaceuticals, Inc. | 3 | $37 |
Products named: Ozempic, CAPLYTA, QULIPTA, UBRELVY, Azstarys, YUPELRI, Wegovy, REXULTI.
Industry payments across IN — which companies pay providers there.
